A new study published in the journal Addiction Neuroscience provides evidence that cannabidiol may help prevent the ...

Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...

GreenWay Herbal Products, LLC today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,496,307 on December 16, 2025, covering a 1-to-1 equimolar composition of ...

Hyderabad: Biophore India Pharmaceuticals on Monday announced that it has received approval from the Central Drugs Standard Control Organisation(CDSCO) for the manufacturing and marketing of ...

A new placebo-controlled study has found that a single dose of cannabidiol does not appear to change brain chemistry, reduce alcohol cravings, or influence drinking behavior in youth with alcohol use ...

Among the cannabinoids in cannabis, the main psychoactive compound, THC, often outshines the one that provides a natural anti-anxiety, anti-epileptic and antipsychotic effect. Cannabidiol, or CBD oil, ...

Arno Kroner, DAOM, LAc, operates a private practice in Santa Monica where he specializes in acupuncture, herbal medicine, and integrative medicine. CBD does not get you high, unlike THC. CBD may ...

Cannabidiol (CBD), a non-psychoactive compound in cannabis, is being touted as beneficial for many health conditions, ranging from anxiety to epilepsy. Although much more research is needed to verify ...

Cannabidiol use at 5 mg/kg/day in healthy adults resulted in liver enzyme levels exceeding three times the upper limit of normal in 5.6%, with no significant changes in endocrine hormone levels ...

Although all current antipsychotics act by interfering with the action of dopamine at dopamine D2 receptors, two recent reports showed that 800 to 1000 mg of cannabidiol per day alleviated the signs ...